{"protocolSection": {"identificationModule": {"nctId": "NCT00461032", "orgStudyIdInfo": {"id": "0476-340"}, "secondaryIdInfos": [{"id": "MK0476-340"}, {"id": "2007_539"}], "organization": {"fullName": "Organon and Co", "class": "INDUSTRY"}, "briefTitle": "Montelukast Back to School Asthma Study (0476-340)", "officialTitle": "A Multicenter, Randomized, Double-blind, Placebo-Controlled Parallel Group 8-week Study to Evaluate the Efficacy and Safety of Chewable Montelukast When Initiated at the Start of the School Year in Pediatric Patients With Chronic Asthma"}, "statusModule": {"statusVerifiedDate": "2022-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2006-06"}, "primaryCompletionDateStruct": {"date": "2006-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2006-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-04-13", "studyFirstSubmitQcDate": "2007-04-13", "studyFirstPostDateStruct": {"date": "2007-04-17", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2010-01-12", "resultsFirstSubmitQcDate": "2010-01-12", "resultsFirstPostDateStruct": {"date": "2010-02-04", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2022-01-31", "lastUpdatePostDateStruct": {"date": "2022-02-02", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Organon and Co", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "This study, in children with chronic asthma, evaluates the number of days of worsening asthma during 8 weeks of treatment with montelukast after treatment is started for the first day of school."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 1162, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "1", "type": "EXPERIMENTAL", "description": "montelukast", "interventionNames": ["Drug: montelukast"]}, {"label": "2", "type": "PLACEBO_COMPARATOR", "description": "Placebo", "interventionNames": ["Drug: Comparator: Placebo"]}], "interventions": [{"type": "DRUG", "name": "montelukast", "description": "montelukast 5 mg tablet Once a day (QD) for 8 weeks", "armGroupLabels": ["1"]}, {"type": "DRUG", "name": "Comparator: Placebo", "description": "Placebo to montelukast QD for 8 weeks", "armGroupLabels": ["2"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Mean Percentage of Days With Worsening Asthma (as Measured on Daily Diaries) in Pediatric Asthmatic Participants", "description": "A day of worsening asthma is a day with: increase from baseline in \u03b2-agonist use (\\> 70% and a min increase of 2 puffs); \\> 50% increase from baseline in daytime symptoms score; awake \"all night\"; increase from baseline in inhaled corticosteroid use \u2265 100% or oral corticosteroid rescue for worsening asthma; or unanticipated healthcare utilization.", "timeFrame": "8 Week treatment period initiated at the beginning of a school year"}], "secondaryOutcomes": [{"measure": "Number of Participants With the Occurrence of One or More Health Care Utilizations (as Measured on Daily Diaries)", "description": "Health care utilization is defined as unanticipated asthma care in an office or clinic, emergent or hospital setting.", "timeFrame": "8 Week treatment period initiated at the beginning of a school year"}, {"measure": "Percentage of Days With Increased \u03b2-agonist Use by >70% and a Minimum Increase of 2 Puffs From Baseline (as Measured on Daily Diaries) in Pediatric Asthmatic Participants", "timeFrame": "8 Week treatment period initiated at the beginning of a school year"}, {"measure": "Percentage of Days With Increased Daytime Asthma Symptom Score by >50% From Baseline (as Measured on Daily Diaries) in Pediatric Asthmatic Participants", "description": "Daytime asthma symptom score was calculated as the sum of the responses (0 (best) to 5 (worst)) to three daytime symptom questions.", "timeFrame": "8 Week treatment period initiated at the beginning of a school year"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male and female non-smoking Participants, ages 6 to 14 years, with chronic asthma, history of at least one asthma exacerbation associated with a cold within the past year and a documented history of asthma that required treatment with any asthma medication within 6 months prior to Visit 1\n\nExclusion Criteria:\n\n* Participant cannot have any other acute or chronic pulmonary disorder, or hospitalization for asthma more than three times within one year prior to signing informed consent", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Years", "maximumAge": "14 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Medical Monitor", "affiliation": "Merck Sharp & Dohme LLC", "role": "STUDY_DIRECTOR"}]}, "referencesModule": {"references": [{"pmid": "20674830", "type": "BACKGROUND", "citation": "Weiss KB, Gern JE, Johnston NW, Sears MR, Jones CA, Jia G, Watkins MW, Smugar SS, Edelman JM, Grant EN. The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year. Ann Allergy Asthma Immunol. 2010 Aug;105(2):174-81. doi: 10.1016/j.anai.2010.04.018. Epub 2010 Jul 1."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Participants who were hospitalized for asthma in the 4 weeks prior to randomization or who required excluded medications were excluded from randomization.", "recruitmentDetails": "Participants were randomized at 165 sites in the US and Canada.\n\nTherapy period: June to November 2006 (including screening period).", "groups": [{"id": "FG000", "title": "Placebo", "description": "Montelukast matching-image placebo tablet taken orally once daily at bedtime for 8 weeks."}, {"id": "FG001", "title": "Montelukast 5 mg", "description": "Montelukast 5 mg chewable tablet taken orally once daily (OD) at bedtime for 8 weeks."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "582"}, {"groupId": "FG001", "numSubjects": "580"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "545"}, {"groupId": "FG001", "numSubjects": "536"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "37"}, {"groupId": "FG001", "numSubjects": "44"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "15"}]}, {"type": "Patient Moved or Relocated", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "5"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Placebo", "description": "Montelukast matching-image placebo tablet taken orally once daily at bedtime for 8 weeks."}, {"id": "BG001", "title": "Montelukast 5 mg", "description": "Montelukast 5 mg chewable tablet taken orally once daily (OD) at bedtime for 8 weeks."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "582"}, {"groupId": "BG001", "value": "580"}, {"groupId": "BG002", "value": "1162"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "9.9", "spread": "2.5"}, {"groupId": "BG001", "value": "9.9", "spread": "2.4"}, {"groupId": "BG002", "value": "9.9", "spread": "2.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "236"}, {"groupId": "BG001", "value": "225"}, {"groupId": "BG002", "value": "461"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "346"}, {"groupId": "BG001", "value": "355"}, {"groupId": "BG002", "value": "701"}]}]}]}, {"title": "Daytime Asthma Symptom Score", "description": "The Participant or parent/guardian scored his/her/child's symptoms \\[from 0 (best) to 5 (worst)\\] on a daily basis. Scores were entered into a Participant diary during the 2-week period prior to the start of the study drug.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Units on a Scale", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "1.32", "spread": "1.81"}, {"groupId": "BG001", "value": "1.35", "spread": "1.94"}, {"groupId": "BG002", "value": "1.34", "spread": "1.88"}]}]}]}, {"title": "\u03b2-Agonist Use", "description": "The number of puffs used per day was entered by the Participant or parent/guardian into a Participant diary during the 2-week period prior to the start of the study drug.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "puffs/day", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "0.62", "spread": "1.11"}, {"groupId": "BG001", "value": "0.54", "spread": "0.94"}, {"groupId": "BG002", "value": "0.58", "spread": "1.03"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Mean Percentage of Days With Worsening Asthma (as Measured on Daily Diaries) in Pediatric Asthmatic Participants", "description": "A day of worsening asthma is a day with: increase from baseline in \u03b2-agonist use (\\> 70% and a min increase of 2 puffs); \\> 50% increase from baseline in daytime symptoms score; awake \"all night\"; increase from baseline in inhaled corticosteroid use \u2265 100% or oral corticosteroid rescue for worsening asthma; or unanticipated healthcare utilization.", "populationDescription": "The primary efficacy analysis was based on full-analysis-set (FAS) population. This included all randomized participants who received at least one dose of double-blinded therapy and had a valid efficacy measurement. The percent of worsening asthma days was calculated from at least 7 days of diary data. Missing diary data were not imputed.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of Days", "timeFrame": "8 Week treatment period initiated at the beginning of a school year", "groups": [{"id": "OG000", "title": "Placebo", "description": "Montelukast matching-image placebo tablet taken orally once daily at bedtime for 8 weeks."}, {"id": "OG001", "title": "Montelukast 5 mg", "description": "Montelukast 5 mg chewable tablet taken orally once daily (OD) at bedtime for 8 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "499"}, {"groupId": "OG001", "value": "499"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27.23", "lowerLimit": "24.25", "upperLimit": "30.00"}, {"groupId": "OG001", "value": "24.26", "lowerLimit": "21.52", "upperLimit": "27.01"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With the Occurrence of One or More Health Care Utilizations (as Measured on Daily Diaries)", "description": "Health care utilization is defined as unanticipated asthma care in an office or clinic, emergent or hospital setting.", "populationDescription": "The analysis was based on the FAS population. This included all randomized participants who received at least 1 dose of study medication and had a valid efficacy measurement. Occurrence of one or more health care utilization was derived from the available diary data and was set to missing if no diary data were available.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "8 Week treatment period initiated at the beginning of a school year", "groups": [{"id": "OG000", "title": "Placebo", "description": "Montelukast matching-image placebo tablet taken orally once daily at bedtime for 8 weeks."}, {"id": "OG001", "title": "Montelukast 5 mg", "description": "Montelukast 5 mg chewable tablet taken orally once daily (OD) at bedtime for 8 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "476"}, {"groupId": "OG001", "value": "466"}]}], "classes": [{"title": "Participants requiring Health Care Utilization", "categories": [{"measurements": [{"groupId": "OG000", "value": "70"}, {"groupId": "OG001", "value": "55"}]}]}, {"title": "Participants not requiring Health Care Utilization", "categories": [{"measurements": [{"groupId": "OG000", "value": "406"}, {"groupId": "OG001", "value": "411"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Days With Increased \u03b2-agonist Use by >70% and a Minimum Increase of 2 Puffs From Baseline (as Measured on Daily Diaries) in Pediatric Asthmatic Participants", "populationDescription": "The secondary efficacy analysis was based on full-analysis-set (FAS) population. This included all randomized participants who received at least one dose of double-blinded therapy and had valid efficacy measurement for at least 7 days of diary data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of Days", "timeFrame": "8 Week treatment period initiated at the beginning of a school year", "groups": [{"id": "OG000", "title": "Placebo", "description": "Montelukast matching-image placebo tablet taken orally once daily at bedtime for 8 weeks."}, {"id": "OG001", "title": "Montelukast 5 mg", "description": "Montelukast 5 mg chewable tablet taken orally once daily (OD) at bedtime for 8 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "491"}, {"groupId": "OG001", "value": "495"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7.02", "lowerLimit": "5.80", "upperLimit": "8.23"}, {"groupId": "OG001", "value": "6.04", "lowerLimit": "4.84", "upperLimit": "7.24"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Days With Increased Daytime Asthma Symptom Score by >50% From Baseline (as Measured on Daily Diaries) in Pediatric Asthmatic Participants", "description": "Daytime asthma symptom score was calculated as the sum of the responses (0 (best) to 5 (worst)) to three daytime symptom questions.", "populationDescription": "The secondary efficacy analysis was based on full-analysis-set (FAS) population. This included all randomized participants who received at least one dose of double-blinded therapy and had a valid efficacy measurement. Variables that were measured as the average over the treatment period were defined from at least 7 days of evaluable diary data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of Days", "timeFrame": "8 Week treatment period initiated at the beginning of a school year", "groups": [{"id": "OG000", "title": "Placebo", "description": "Montelukast matching-image placebo tablet taken orally once daily at bedtime for 8 weeks."}, {"id": "OG001", "title": "Montelukast 5 mg", "description": "Montelukast 5 mg chewable tablet taken orally once daily (OD) at bedtime for 8 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "491"}, {"groupId": "OG001", "value": "496"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "17.4", "lowerLimit": "15.33", "upperLimit": "19.47"}, {"groupId": "OG001", "value": "16.03", "lowerLimit": "13.99", "upperLimit": "18.07"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Adverse events (AEs) were collected during the 8 week, double-blind treatment period, and up to and including 14 days after the last dose of study therapy", "description": "The number of participants listed in the AE tables (566 placebo \\& 566 montelukast) is the number that received treatment. 16 placebo \\& 14 montelukast randomized participants did not receive treatment.\n\nAlthough a participant may have 2 or more AEs they are counted only once in a category. The same participant may appear in other categories.", "eventGroups": [{"id": "EG000", "title": "Placebo", "description": "Montelukast matching-image placebo tablet taken orally once daily at bedtime for 8 weeks.", "seriousNumAffected": 1, "seriousNumAtRisk": 566, "otherNumAffected": 189, "otherNumAtRisk": 566}, {"id": "EG001", "title": "Montelukast 5 mg", "description": "Montelukast 5 mg chewable tablet taken orally once daily (OD) at bedtime for 8 weeks.", "seriousNumAffected": 4, "seriousNumAtRisk": 566, "otherNumAffected": 191, "otherNumAtRisk": 566}], "seriousEvents": [{"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}], "otherEvents": [{"term": "Lymphadenopathy", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Lymphangioma", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Ear pain", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Conjunctivitis", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Abdominal discomfort", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Gastrooesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Haematochezia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 566}]}, {"term": "Stomach discomfort", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Toothache", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 566}]}, {"term": "Chest discomfort", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Malaise", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 566}]}, {"term": "Allergy to arthropod bite", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Acarodermatitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Acute sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Body tinea", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Bronchiolitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Bronchitis acute", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Ear infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Eye infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Folliculitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Gastroenteritis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 566}]}, {"term": "Herpes simplex", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Hordeolum", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Impetigo", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Labyrinthitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 24, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 566}]}, {"term": "Otitis externa", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Otitis media", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 566}]}, {"term": "Otitis media acute", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Pharyngitis streptococcal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 566}]}, {"term": "Pharyngotonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Pneumonia viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 566}]}, {"term": "Skin infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Staphylococcal infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Subcutaneous abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 45, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 566}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Varicella", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 566}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 566}]}, {"term": "Arthropod bite", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Arthropod sting", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Foot fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Foreign body in eye", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Hand fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Joint sprain", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Neck injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Soft tissue injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Tibia fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Upper limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Weight decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Anorexia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Exostosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Joint effusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Tendonitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 566}]}, {"term": "Lethargy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Migraine", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Sinus headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Insomnia", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Mood swings", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Sleep terror", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Urinary incontinence", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Nipple pain", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Nipple swelling", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 28, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 21, "numAtRisk": 566}]}, {"term": "Bronchial hyperreactivity", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Bronchospasm", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 566}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Nasal congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 566}]}, {"term": "Nocturnal dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Pharyngolaryngeal pain", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 13, "numAtRisk": 566}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 566}]}, {"term": "Rhinorrhoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Sinus congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Sneezing", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Upper respiratory tract congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Wheezing", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 566}]}, {"term": "Dermatitis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Dermatitis contact", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Erythema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Pruritus", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 566}]}, {"term": "Rash generalised", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Seborrhoea", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}, {"term": "Skin irritation", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Skin lesion", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 566}]}, {"term": "Endodontic procedure", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 566}]}, {"term": "Wisdom teeth removal", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 9.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 566}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 566}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."}, "pointOfContact": {"title": "Senior Vice President, Global Clinical Development", "organization": "Merck Sharp & Dohme Corp.", "email": "ClinicalTrialsDisclosure@merck.com", "phone": "1-800-672-6372"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000093875", "term": "Montelukast"}], "ancestors": [{"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000020024", "term": "Leukotriene Antagonists"}, {"id": "D000006727", "term": "Hormone Antagonists"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000065694", "term": "Cytochrome P-450 CYP1A2 Inducers"}, {"id": "D000065693", "term": "Cytochrome P-450 Enzyme Inducers"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M274108", "name": "Montelukast", "asFound": "Means", "relevance": "HIGH"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M21876", "name": "Leukotriene Antagonists", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}